Using machine learning to design phages with enhanced therapeutic features
June 8, 2021 at 5:00 PM Pacific Time
Co-founder at Felix Biotechnology
Robert McBride is the co-founder at Felix Biotechnology. Felix Biotechnology is focused on accelerating the deployment of novel biotherapeutics targeting urgent microbial challenges in human health and beyond. Felix Biotechnology recently announced initiation of a clinical trial using phage for Pseudomonas infections.